Respiratory syncytial virus (RSV) causes chest infections and is the leading cause of hospitalizations among children under one in the U.S. This study – led by K.K. McLaurin, from AstraZeneca in Gaithersburg, Maryland – looked at whether premature babies are more likely than full-term ones to be admitted to hospital with RSV in their first year. The study looked at four million babies born between 2003 and 2013 and found that children born prematurely and those hospitalized at less than 90 days old had more severe and more costly RSV hospitalizations during their first year of life.
You can read the abstract of this article here.